Harrisburg Daily Digest
SEE OTHER BRANDS

The latest news from Pennsylvania

Harrisburg Daily Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.

Press releases published on April 8, 2025

Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, …

CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue Common Stock in connection with the Merger with ESSA Bancorp, Inc., the Proposal to Approve the 2025 Omnibus Incentive Plan and the Say-on-Pay Proposal

CNB Financial Corporation Announces that ISS Recommends Shareholders Support the Proposal to Issue Common Stock in connection with the Merger with ESSA Bancorp, Inc., the Proposal to Approve the 2025 Omnibus Incentive Plan and the Say-on-Pay Proposal

CLEARFIELD, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE) is pleased to announce that leading independent proxy advisory firm Institutional Shareholder Services Inc (“ISS”) is recommending that CNB shareholders …

Clean Earth Rolls Out New Fleet Nationwide, Enhancing Sustainability and Service Efficiency

Clean Earth Rolls Out New Fleet Nationwide, Enhancing Sustainability and Service Efficiency

New trucks feature innovative modular design and technology-driven advancements, enhancing safety, compliance, and customer service. KING OF PRUSSIA, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Clean Earth, a division of Enviri Corporation (NYSE: NVRI) and a …

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

PITTSBURGH, April 08, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service